|
⚲
|
| Keyboard |
| Owen Adams Catherine
✚
|
|
|---|---|
| CIK # | 0001816838 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001816838] | |
| 4 | [0001816838] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Owen Adams Catherine | |
| Agios Pharmaceuticals Inc | |
| Acadia Pharmaceuticals Inc | |
| OptiNose Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Acadia Pharmaceuticals Inc ACAD
Common Stock
|
2026-03-25 | Sell | 11,641 | $21.47 | 249,932 |
|
Acadia Pharmaceuticals Inc ACAD
Restricted Stock Units · derivative
|
2026-03-24 | Option exercise | 23,509 | $0.00 | |
|
Acadia Pharmaceuticals Inc ACAD
Common Stock
|
2026-03-24 | Option exercise | 23,509 | $0.00 | |
|
Acadia Pharmaceuticals Inc ACAD
Restricted Stock Units · derivative
|
2026-03-06 | Grant | 76,509 | $0.00 | |
|
Acadia Pharmaceuticals Inc ACAD
Stock Option (Right to Buy) · derivative
|
2026-03-06 | Grant | 263,005 | $0.00 | |
|
Agios Pharmaceuticals Inc AGIO
Restricted stock units · derivative
|
2025-06-20 | Option exercise | 2,120 | $0.00 | |
|
Agios Pharmaceuticals Inc AGIO
Common stock
|
2025-06-20 | Option exercise | 2,120 | $0.00 | |
|
Agios Pharmaceuticals Inc AGIO
Stock options (right to buy) · derivative
|
2025-06-18 | Grant | 15,768 | $0.00 | |
|
Agios Pharmaceuticals Inc AGIO
Restricted stock units · derivative
|
2025-06-18 | Grant | 2,816 | $0.00 | |
|
Agios Pharmaceuticals Inc AGIO
Common stock
|
2025-06-13 | Option exercise | 1,977 | $0.00 | |
|
Agios Pharmaceuticals Inc AGIO
Restricted stock units · derivative
|
2025-06-13 | Option exercise | 1,977 | $0.00 | |
|
Acadia Pharmaceuticals Inc ACAD
Restricted Stock Units · derivative
|
2025-03-24 | Grant | 94,039 | $0.00 | |
|
Acadia Pharmaceuticals Inc ACAD
Stock Option (Right to Buy) · derivative
|
2025-03-24 | Grant | 319,976 | $0.00 | |
|
Acadia Pharmaceuticals Inc ACAD
Stock Option (Right to Buy) · derivative
|
2024-09-23 | Grant | 353,261 | $0.00 | |
|
Agios Pharmaceuticals Inc AGIO
Stock options (right to buy) · derivative
|
2024-06-20 | Grant | 11,774 | $0.00 | |
|
Agios Pharmaceuticals Inc AGIO
Restricted stock units · derivative
|
2024-06-20 | Grant | 2,120 | $0.00 | |
|
Agios Pharmaceuticals Inc AGIO
Restricted stock units · derivative
|
2024-06-13 | Option exercise | 1,976 | $0.00 | |
|
Agios Pharmaceuticals Inc AGIO
Common stock
|
2024-06-13 | Option exercise | 1,976 | $0.00 | |
|
OptiNose Inc OPTN
Stock Option (Right to Buy) · derivative
|
2024-06-06 | Grant | 75,000 | $0.00 | |
|
Agios Pharmaceuticals Inc AGIO
Restricted stock units · derivative
|
2023-06-13 | Grant | 5,929 | $0.00 | |
| showing 20 of 26 most recent transactions | |||||